Tabla de contenido
I
NTRODUCTION
D
ÉFINITIONS
%G OCPWGN EQPVKGPV FGU VGTOGU GV FGU KEÊPGU UR¾EKCNGU SWK CRRCTCKUUGPV FCPU NC OCTIG
GV FQPV NC HQPEVKQP GUV F CVVKTGT XQVTG CVVGPVKQP UWT FGU KPHQTOCVKQPU UR¾EKHKSWGU
KORQTVCPVGU
#8'46+55'/'06
!
8QWU OGV GP ICTFG EQPVTG NG TKUSWG FG DNGUUWTG
#66'06+10
!
'ZRNKECVKQP FGU OGUWTGU RCTVKEWNK½TGU RGTOGVVCPV F CUUWTGT WPG WVKNKUCVKQP GHHKECEG GV
UÑTG FG N CRRCTGKN
4GOCTSWG TGOCTSWG KPHQTOCVKXG QW WVKNG
R
ESPONSABILITÉ DE L
. WVKNKUCVGWT QW NG RTQRTK¾VCKTG FG EGV CRRCTGKN UGTC VGPW RQWT UGWN TGURQPUCDNG FG VQWVG
DNGUUWTG QW FG VQWV FQOOCIG OCV¾TKGN T¾UWNVCPV
F WPG WVKNKUCVKQP PQP EQPHQTOG CWZ KPUVTWEVKQPU HQWTPKGU
•
F WP GPVTGVKGP QW FG OQFKHKECVKQPU T¾CNKU¾U PQP EQPHQTO¾OGPV CWZ KPUVTWEVKQPU GV
•
QW RCT FGU RGTUQPPGU PQP CWVQTKU¾GU
8GWKNNG\ NKTG EG OCPWGN CVVGPVKXGOGPV CXCPV F WVKNKUGT N CRRCTGKN
I
NFORMATIONS MÉDICALES
U
SAGE PRÉVU POUR LA
.C S7™ E
R
LITE
F CRP¾G QDUVTWEVKXG FW UQOOGKN
5#15 . JWOKFKHKECVGWT KPV¾IT¾ QRVKQPPGN
i™ QW
H
A
2
UMID
IRE
T¾EJCWHHGOGPV FG N CKT F¾NKXT¾ RCT NC S7 E
R
M
N
H
ES
ED
UMID
FQOKEKNG QW GP OKNKGW JQURKVCNKGT
#66'06+10
75# 70+37'/'06
!
5GNQP NC NQK H¾F¾TCNG CO¾TKECKPG EG FKURQUKVKH PG RGWV ¿VTG XGPFW CWZ 75# SWG RCT QW
UWT QTFTG F WP O¾FGEKP
'
/
UTILISATEUR
DU PROPRIÉTAIRE
S7™ E
R
LITE
M
GUV EQP¼WG RQWT NG VTCKVGOGPV FGU CFWNVGU CVVGKPVU FW U[PFTQOG
ES
ED
iC™ GUV RT¾XW RQWT N JWOKFKHKECVKQP GV NG
H
A
2
UMID
IRE
i GV N
A
2
H
A
IRE
UMID
M
ES
ED
R
M
. CRRCTGKN FG 22% S7 E
LITE
ES
ED
iC UQPV RT¾XWU RQWT WPG WVKNKUCVKQP ¯
2
IRE
LITE
I
39
NTRODUCTION
Capítulos
Tabla de contenido
Solución de problemas
